FDA "concerned" with lack of animal testing, non-validated in vitro alternative assays.
This article was originally published in The Rose Sheet
Executive Summary
FDA "CONCERNED" WITH LACK OF ANIMAL TESTING IN COSMETIC SAFETY ASSESSMENTS and the increased use of in vitro alter-native tests that have not been validated, FDA's Office of Cosmetics and Colors Skin Absorption and Metabolism Section Chief Robert Bronaugh, PhD, said at the Society of Cosmetic Chemists mid-Atlantic meeting in Baltimore, Md. on Nov. 12. "It appears that now quite frequently new products seem to go straight to clinical testing" without initial animal testing, Bronaugh said. He noted that FDA has doubts about the elimination of animal testing given the lack of "suitable in vitro tests."